<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36458566</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>31</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>06</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1096-9071</ISSN><JournalIssue CitedMedium="Internet"><Volume>95</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Journal of medical virology</Title><ISOAbbreviation>J Med Virol</ISOAbbreviation></Journal><ArticleTitle>Liquid biomarkers of macrophage dysregulation and circulating spike protein illustrate the biological heterogeneity in patients with post-acute sequelae of COVID-19.</ArticleTitle><Pagination><StartPage>e28364</StartPage><MedlinePgn>e28364</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e28364</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1002/jmv.28364</ELocationID><Abstract><AbstractText>Post-acute sequelae of COVID-19 (PASC) are long-term consequences of SARS-CoV-2 infection that can substantially impair the quality of life. Underlying mechanisms ranging from persistent viruses to innate and adaptive immune dysregulation have been discussed. Here, we profiled the plasma of 181 individuals from the cohort study for digital health research in Germany (DigiHero), including individuals after mild to moderate COVID-19 with or without PASC and uninfected controls. We focused on soluble factors related to monocyte/macrophage biology and on circulating SARS-CoV-2 spike (S1) protein as a potential biomarker for persistent viral reservoirs. At a median time of 8 months after infection, we found pronounced dysregulation in almost all tested soluble factors, including both pro-inflammatory and pro-fibrotic cytokines. These immunological perturbations were remarkably independent of ongoing PASC symptoms per se, but further correlation and regression analyses suggested PASC-specific&#xa0;patterns involving CCL2/MCP-1 and IL-8 that either correlated with sCD162, sCD206/MMR, IFN-&#x3b1;2, IL-17A and IL-33, or IL-18 and IL-23. None of the analyzed factors correlated with the detectability or levels of circulating S1, indicating that this represents an independent subset of patients with PASC. These&#xa0;data confirm&#xa0;prior evidence of immune dysregulation and persistence of viral protein in PASC and illustrate&#xa0;its biological heterogeneity that still awaits correlation with clinically defined PASC subtypes.</AbstractText><CopyrightInformation>&#xa9; 2022 The Authors. Journal of Medical Virology published by Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Schulthei&#xdf;</LastName><ForeName>Christoph</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-9789-5776</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine IV, Oncology/Hematology, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Willscher</LastName><ForeName>Edith</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-8786-4578</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine IV, Oncology/Hematology, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paschold</LastName><ForeName>Lisa</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-0020-1315</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine IV, Oncology/Hematology, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gottschick</LastName><ForeName>Cornelia</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-5822-1055</Identifier><AffiliationInfo><Affiliation>Institute for Medical Epidemiology, Biometrics and Informatics (IMEBI), Interdisciplinary Center for Health Sciences, Medical School of the Martin-Luther University Halle-Wittenberg, Halle (Saale), Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klee</LastName><ForeName>Bianca</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Institute for Medical Epidemiology, Biometrics and Informatics (IMEBI), Interdisciplinary Center for Health Sciences, Medical School of the Martin-Luther University Halle-Wittenberg, Halle (Saale), Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bosurgi</LastName><ForeName>Lidia</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-8775-4950</Identifier><AffiliationInfo><Affiliation>I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Protozoa Immunology, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dutzmann</LastName><ForeName>Jochen</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiology and Intensive Care Medicine,&#xa0;Mid-German Heart Center, University Hospital, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sedding</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-7312-5216</Identifier><AffiliationInfo><Affiliation>Department of Cardiology and Intensive Care Medicine,&#xa0;Mid-German Heart Center, University Hospital, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frese</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Institute of General Practice and Family Medicine, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Girndt</LastName><ForeName>Matthias</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-2823-0847</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine II, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>H&#xf6;ll</LastName><ForeName>Jessica I</ForeName><Initials>JI</Initials><AffiliationInfo><Affiliation>Pediatric Hematology and Oncology, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gekle</LastName><ForeName>Michael</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-1581-8767</Identifier><AffiliationInfo><Affiliation>Julius Bernstein-Institute of Physiology, Faculty of Medicine, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mikolajczyk</LastName><ForeName>Rafael</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-1271-7204</Identifier><AffiliationInfo><Affiliation>Institute for Medical Epidemiology, Biometrics and Informatics (IMEBI), Interdisciplinary Center for Health Sciences, Medical School of the Martin-Luther University Halle-Wittenberg, Halle (Saale), Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Binder</LastName><ForeName>Mascha</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-0663-3004</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine IV, Oncology/Hematology, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Med Virol</MedlineTA><NlmUniqueID>7705876</NlmUniqueID><ISSNLinking>0146-6615</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000657845">spike protein, SARS-CoV-2</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064370" MajorTopicYN="Y">Spike Glycoprotein, Coronavirus</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008264" MajorTopicYN="N">Macrophages</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS coronavirus</Keyword><Keyword MajorTopicYN="N">cytokine/chemokine</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">macrophage</Keyword><Keyword MajorTopicYN="N">monocyte</Keyword></KeywordList><CoiStatement>The authors declare no conflict&#xa0;of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>10</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>2</Day><Hour>5</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>12</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36458566</ArticleId><ArticleId IdType="pmc">PMC9878213</ArticleId><ArticleId IdType="doi">10.1002/jmv.28364</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Merad M, Blish CA, Sallusto F, Iwasaki A. The immunology and immunopathology of COVID&#x2010;19. Science. 2022;375(6585):1122&#x2010;1127. 10.1126/science.abm8108</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abm8108</ArticleId><ArticleId IdType="pubmed">35271343</ArticleId></ArticleIdList></Reference><Reference><Citation>Osuchowski MF, Winkler MS, Skirecki T, et al. The COVID&#x2010;19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity. Lancet Respir&#xa0;Med. 2021;9(6):622&#x2010;642. 10.1016/S2213-2600(21)00218-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00218-6</ArticleId><ArticleId IdType="pmc">PMC8102044</ArticleId><ArticleId IdType="pubmed">33965003</ArticleId></ArticleIdList></Reference><Reference><Citation>Dan JM, Mateus J, Kato Y, et al. Immunological memory to SARS&#x2010;CoV&#x2010;2 assessed for up to 8 months after infection. Science. 2021;371(6529):eabf4063. 10.1126/science.abf4063</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abf4063</ArticleId><ArticleId IdType="pmc">PMC7919858</ArticleId><ArticleId IdType="pubmed">33408181</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, et al. Post&#x2010;acute COVID&#x2010;19 syndrome. Nat&#xa0;Med. 2021;27(4):601&#x2010;615. 10.1038/s41591-021-01283-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehandru S, Merad M. Pathological sequelae of long&#x2010;haul COVID. Nat&#xa0;Immunol. 2022;23(2):194&#x2010;202. 10.1038/s41590-021-01104-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01104-y</ArticleId><ArticleId IdType="pmc">PMC9127978</ArticleId><ArticleId IdType="pubmed">35105985</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulthei&#xdf; C, Willscher E, Paschold L, et al. The IL&#x2010;1&#x3b2;, IL&#x2010;6, and TNF cytokine triad is associated with post&#x2010;acute sequelae of COVID&#x2010;19. Cell Rep&#xa0;Med. 2022;3(6):100663. 10.1016/j.xcrm.2022.100663</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2022.100663</ArticleId><ArticleId IdType="pmc">PMC9214726</ArticleId><ArticleId IdType="pubmed">35732153</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballering AV, van Zon SKR, Olde Hartman TC, Rosmalen JGM. Persistence of somatic symptoms after COVID&#x2010;19 in the Netherlands: an observational cohort study. Lancet. 2022;400(10350):452&#x2010;461. 10.1016/S0140-6736(22)01214-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01214-4</ArticleId><ArticleId IdType="pmc">PMC9352274</ArticleId><ArticleId IdType="pubmed">35934007</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Xu E, Bowe B, Al&#x2010;Aly Z. Long&#x2010;term cardiovascular outcomes of COVID&#x2010;19. Nat&#xa0;Med. 2022;28(3):583&#x2010;590. 10.1038/s41591-022-01689-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01689-3</ArticleId><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen EL, Go&#xdf;ling A, Adam G, et al. Multi&#x2010;organ assessment in mainly non&#x2010;hospitalized individuals after SARS&#x2010;CoV&#x2010;2 infection: The Hamburg City Health Study COVID Programme. Eur Heart J. 2022;43(11):1124&#x2010;1137. 10.1093/eurheartj/ehab914</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehab914</ArticleId><ArticleId IdType="pmc">PMC8755397</ArticleId><ArticleId IdType="pubmed">34999762</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, Yuan D, Chen DG, et al. Multiple early factors anticipate post&#x2010;acute COVID&#x2010;19 sequelae. Cell. 2022;185(5):881&#x2010;895. 10.1016/j.cell.2022.01.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Al&#x2010;Aly Z, Bowe B, Xie Y. Long COVID after breakthrough SARS&#x2010;CoV&#x2010;2 infection. Nat&#xa0;Med. 2022;28(7):1461&#x2010;1467. 10.1038/s41591-022-01840-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01840-0</ArticleId><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Vibholm LK, Nielsen SSF, Pahus MH, et al. SARS&#x2010;CoV&#x2010;2 persistence is associated with antigen&#x2010;specific CD8 T&#x2010;cell responses. EBioMedicine. 2021;64:103230. 10.1016/j.ebiom.2021.103230</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103230</ArticleId><ArticleId IdType="pmc">PMC7847186</ArticleId><ArticleId IdType="pubmed">33530000</ArticleId></ArticleIdList></Reference><Reference><Citation>Noval Rivas M, Porritt RA, Cheng MH, Bahar I, Arditi M. Multisystem inflammatory syndrome in children and long COVID: the SARS&#x2010;CoV&#x2010;2 viral superantigen hypothesis. Front Immunol. 2022;13:941009. 10.3389/fimmu.2022.941009</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.941009</ArticleId><ArticleId IdType="pmc">PMC9300823</ArticleId><ArticleId IdType="pubmed">35874696</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C, Darley DR, Wilson DB, et al. Immunological dysfunction persists for 8 months following initial mild&#x2010;to&#x2010;moderate SARS&#x2010;CoV&#x2010;2 infection. Nat&#xa0;Immunol. 2022;23(2):210&#x2010;216. 10.1038/s41590-021-01113-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Zollner A, Koch R, Jukic A, et al. Postacute COVID&#x2010;19 is characterized by gut viral antigen persistence in inflammatory bowel diseases. Gastroenterology. 2022;163(2):495&#x2010;506. 10.1053/j.gastro.2022.04.037</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2022.04.037</ArticleId><ArticleId IdType="pmc">PMC9057012</ArticleId><ArticleId IdType="pubmed">35508284</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun J, Xiao J, Sun R, et al. Prolonged persistence of SARS&#x2010;CoV&#x2010;2 RNA in body fluids. Emerging Infect Dis. 2020;26(8):1834&#x2010;1838. 10.3201/eid2608.201097</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2608.201097</ArticleId><ArticleId IdType="pmc">PMC7392422</ArticleId><ArticleId IdType="pubmed">32383638</ArticleId></ArticleIdList></Reference><Reference><Citation>Swank Z, Senussi Y, Manickas&#x2010;Hill Z, et al. Persistent circulating severe acute respiratory syndrome coronavirus 2 spike is associated with post&#x2010;acute coronavirus disease 2019 sequelae. Clin Infect Dis. 2022. 10.1093/cid/ciac722</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac722</ArticleId><ArticleId IdType="pmc">PMC10169416</ArticleId><ArticleId IdType="pubmed">36052466</ArticleId></ArticleIdList></Reference><Reference><Citation>Guler SA, Ebner L, Aubry&#x2010;Beigelman C, et al. Pulmonary function and radiological features 4 months after COVID&#x2010;19: first results from the national prospective observational Swiss COVID&#x2010;19 lung study. Eur Respir J. 2021;57(4):2003690. 10.1183/13993003.03690-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.03690-2020</ArticleId><ArticleId IdType="pmc">PMC8082329</ArticleId><ArticleId IdType="pubmed">33419891</ArticleId></ArticleIdList></Reference><Reference><Citation>Toraldo DM, Satriano F, Rollo R, et al. COVID&#x2010;19 IgG/IgM patterns, early IL&#x2010;6 elevation and long&#x2010;term radiological sequelae in 75 patients hospitalized due to interstitial pneumonia followed up from 3 to 12 months. PLoS One. 2022;17(2):e0262911. 10.1371/journal.pone.0262911</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0262911</ArticleId><ArticleId IdType="pmc">PMC8863277</ArticleId><ArticleId IdType="pubmed">35192635</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin Y, Wu J, Chen T, et al. Long&#x2010;term microstructure and cerebral blood flow changes in patients recovered from COVID&#x2010;19 without neurological manifestations. J Clin Invest. 2021;131(8):e147329. 10.1172/JCI147329</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI147329</ArticleId><ArticleId IdType="pmc">PMC8262559</ArticleId><ArticleId IdType="pubmed">33630760</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang EY, Mao T, Klein J, et al. Diverse functional autoantibodies in patients with COVID&#x2010;19. Nature. 2021;595(7866):283&#x2010;288. 10.1038/s41586-021-03631-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03631-y</ArticleId><ArticleId IdType="pubmed">34010947</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulthei&#xdf; C, Paschold L, Willscher E, et al. Maturation trajectories and transcriptional landscape of plasmablasts and autoreactive B cells in COVID&#x2010;19. iScience. 2021;24:103325. 10.1016/j.isci.2021.103325</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2021.103325</ArticleId><ArticleId IdType="pmc">PMC8536484</ArticleId><ArticleId IdType="pubmed">34723157</ArticleId></ArticleIdList></Reference><Reference><Citation>Porritt RA, Binek A, Paschold L, et al. The autoimmune signature of hyperinflammatory multisystem inflammatory syndrome in children. J Clin Invest. 2021;131(20):e151520. 10.1172/JCI151520</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI151520</ArticleId><ArticleId IdType="pmc">PMC8516454</ArticleId><ArticleId IdType="pubmed">34437303</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q, Bastard P, Effort CHG, Cobat A, Casanova JL. Human genetic and immunological determinants of critical COVID19 pneumonia. Nature 2022;603:587&#x2010;598. 10.1038/s41586-022-04447-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04447-0</ArticleId><ArticleId IdType="pmc">PMC8957595</ArticleId><ArticleId IdType="pubmed">35090163</ArticleId></ArticleIdList></Reference><Reference><Citation>Haran JP, Bradley E, Zeamer AL, et al. Inflammation&#x2010;type dysbiosis of the oral microbiome associates with the duration of COVID&#x2010;19 symptoms and long COVID. JCI Insight. 2021;6(20):e152346. 10.1172/jci.insight.152346</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.152346</ArticleId><ArticleId IdType="pmc">PMC8564890</ArticleId><ArticleId IdType="pubmed">34403368</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q, Mak JWY, Su Q, et al. Gut microbiota dynamics in a prospective cohort of patients with post&#x2010;acute COVID&#x2010;19 syndrome. Gut. 2022;71(3):544&#x2010;552. 10.1136/gutjnl-2021-325989</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-325989</ArticleId><ArticleId IdType="pubmed">35082169</ArticleId></ArticleIdList></Reference><Reference><Citation>Theobald SJ, Simonis A, Georgomanolis T, et al. Long&#x2010;lived macrophage reprogramming drives spike protein&#x2010;mediated inflammasome activation in COVID&#x2010;19. EMBO Mol Med. 2021;13(8):e14150. 10.15252/emmm.202114150</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.202114150</ArticleId><ArticleId IdType="pmc">PMC8350892</ArticleId><ArticleId IdType="pubmed">34133077</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohnacker S, Hartung F, Henkel F, et al. Mild COVID&#x2010;19 imprints a long&#x2010;term inflammatory eicosanoid&#x2010; and chemokine memory in monocyte&#x2010;derived macrophages. Mucosal Immunol. 2022;15:515&#x2010;524. 10.1038/s41385-021-00482-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41385-021-00482-8</ArticleId><ArticleId IdType="pmc">PMC9038526</ArticleId><ArticleId IdType="pubmed">35288643</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte KI, Catahay JA, Velasco JV, et al. Impact of COVID&#x2010;19 vaccination on the risk of developing long&#x2010;COVID and on existing long&#x2010;COVID symptoms: a systematic review. EClinicalMedicine. 2022;53:101624. 10.1016/j.eclinm.2022.101624</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101624</ArticleId><ArticleId IdType="pmc">PMC9417563</ArticleId><ArticleId IdType="pubmed">36051247</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuchida T, Hirose M, Inoue Y, Kunishima H, Otsubo T, Matsuda T. Relationship between changes in symptoms and antibody titers after a single vaccination in patients with long COVID. J Med Virol. 2022;94(7):3416&#x2010;3420. 10.1002/jmv.27689</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27689</ArticleId><ArticleId IdType="pmc">PMC9088489</ArticleId><ArticleId IdType="pubmed">35238053</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucas C, Wong P, Klein J, et al. Longitudinal analyses reveal immunological misfiring in severe COVID&#x2010;19. Nature. 2020;584(7821):463&#x2010;469. 10.1038/s41586-020-2588-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2588-y</ArticleId><ArticleId IdType="pmc">PMC7477538</ArticleId><ArticleId IdType="pubmed">32717743</ArticleId></ArticleIdList></Reference><Reference><Citation>Idiz UO, Yurttas TT, Degirmencioglu S, et al. Immunophenotyping of lymphocytes and monocytes and the status of cytokines in the clinical course of Covid&#x2010;19 patients. J Med Virol. 2022;94:4744&#x2010;4753. 10.1002/jmv.27917</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27917</ArticleId><ArticleId IdType="pmc">PMC9348494</ArticleId><ArticleId IdType="pubmed">35667877</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling L, Chen Z, Lui G, et al. Longitudinal cytokine profile in patients with mild to critical COVID&#x2010;19. Front Immunol. 2021;12:763292. 10.3389/fimmu.2021.763292</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.763292</ArticleId><ArticleId IdType="pmc">PMC8685399</ArticleId><ArticleId IdType="pubmed">34938289</ArticleId></ArticleIdList></Reference><Reference><Citation>Gantzel RH, Kj&#xe6;r MB, Laursen TL, et al. Macrophage activation markers, soluble CD163 and mannose receptor, in liver fibrosis. Front Med. 2021;7:615599. 10.3389/fmed.2020.615599</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.615599</ArticleId><ArticleId IdType="pmc">PMC7820116</ArticleId><ArticleId IdType="pubmed">33490096</ArticleId></ArticleIdList></Reference><Reference><Citation>Talla A, Vasaikar SV, Lemos MP, et al. Longitudinal immune dynamics of mild COVID&#x2010;19 define signatures of recovery and persistence. bioRxiv. 2021. 10.1101/2021.05.26.442666</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.05.26.442666</ArticleId></ArticleIdList></Reference><Reference><Citation>Arish M, Qian W, Narasimhan H, Sun J. COVID&#x2010;19 immunopathology: from acute diseases to chronic sequelae. J Med Virol. 2022. 10.1002/jmv.28122</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28122</ArticleId><ArticleId IdType="pmc">PMC9537925</ArticleId><ArticleId IdType="pubmed">36056655</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulthei&#xdf; C, Paschold L, Simnica D, et al. Next&#x2010;generation sequencing of T and B cell receptor repertoires from COVID&#x2010;19 patients showed signatures associated with severity of disease. Immunity. 2020;53(2):442&#x2010;455. 10.1016/j.immuni.2020.06.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2020.06.024</ArticleId><ArticleId IdType="pmc">PMC7324317</ArticleId><ArticleId IdType="pubmed">32668194</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogata AF, Cheng CA, Desjardins M, et al. Circulating severe acute respiratory syndrome coronavirus 2 (SARS&#x2010;CoV&#x2010;2) vaccine antigen detected in the plasma of mRNA&#x2010;1273 vaccine recipients. Clin Infect Dis. 2022;74(4):715&#x2010;718. 10.1093/cid/ciab465</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab465</ArticleId><ArticleId IdType="pmc">PMC8241425</ArticleId><ArticleId IdType="pubmed">34015087</ArticleId></ArticleIdList></Reference><Reference><Citation>Bansal S, Perincheri S, Fleming T, et al. Cutting edge: circulating exosomes with COVID spike protein are induced by BNT162b2 (Pfizer&#x2010;BioNTech) vaccination prior to development of antibodies: a novel mechanism for immune activation by mRNA vaccines. J&#xa0;Immunol. 2021;207(10):2405&#x2010;2410. 10.4049/jimmunol.2100637</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.2100637</ArticleId><ArticleId IdType="pmc">PMC11073804</ArticleId><ArticleId IdType="pubmed">34654691</ArticleId></ArticleIdList></Reference><Reference><Citation>Knoll R, Schultze JL, Schulte&#x2010;Schrepping J. Monocytes and macrophages in COVID&#x2010;19. Front Immunol. 2021;12:720109. 10.3389/fimmu.2021.720109</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.720109</ArticleId><ArticleId IdType="pmc">PMC8335157</ArticleId><ArticleId IdType="pubmed">34367190</ArticleId></ArticleIdList></Reference><Reference><Citation>Merad M, Martin JC. Pathological inflammation in patients with COVID&#x2010;19: a key role for monocytes and macrophages. Nat Rev Immunol. 2020;20(6):355&#x2010;362. 10.1038/s41577-020-0331-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0331-4</ArticleId><ArticleId IdType="pmc">PMC7201395</ArticleId><ArticleId IdType="pubmed">32376901</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H, Li X, Wu Q, et al. Plasma proteomic and metabolomic characterization of COVID&#x2010;19 survivors 6 months after discharge. Cell Death Dis. 2022;13(3):235. 10.1038/s41419-022-04674-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-022-04674-3</ArticleId><ArticleId IdType="pmc">PMC8919172</ArticleId><ArticleId IdType="pubmed">35288537</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson BK, Francisco EB, Yogendra R, et al. Persistence of SARS CoV&#x2010;2 S1 protein in CD16+ monocytes in post&#x2010;acute sequelae of COVID&#x2010;19 (PASC) up to 15 months post&#x2010;infection. Front Immunol. 2022;12:746021. 10.3389/fimmu.2021.746021</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.746021</ArticleId><ArticleId IdType="pmc">PMC8784688</ArticleId><ArticleId IdType="pubmed">35082777</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovarik JJ, Bileck A, Hagn G, et al. Multi&#x2010;omics provide evidence for an anti&#x2010;inflammatory immune signature and metabolic alterations in patients with long COVID syndrome &#x2013; an exploratory study. medRxiv. 2022.</Citation></Reference><Reference><Citation>Brauns E, Azouz A, Grimaldi D, et al. Functional reprogramming of monocytes in patients with acute and convalescent severe COVID&#x2010;19. JCI Insight. 2022;7(9):e154183. 10.1172/jci.insight.154183</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.154183</ArticleId><ArticleId IdType="pmc">PMC9090263</ArticleId><ArticleId IdType="pubmed">35380990</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein J, Wood J, Jaycox J, et al. Distinguishing features of long COVID identified through immune profiling. medRxiv. 2022. 10.1101/2022.08.09.22278592</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.08.09.22278592</ArticleId><ArticleId IdType="pmc">PMC10620090</ArticleId><ArticleId IdType="pubmed">37748514</ArticleId></ArticleIdList></Reference><Reference><Citation>Dagher R, Copenhaver AM, Besnard V, et al. IL&#x2010;33&#x2010;ST2 axis regulates myeloid cell differentiation and activation enabling effective club cell regeneration. Nat Commun. 2020;11(1):4786. 10.1038/s41467-020-18466-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-18466-w</ArticleId><ArticleId IdType="pmc">PMC7508874</ArticleId><ArticleId IdType="pubmed">32963227</ArticleId></ArticleIdList></Reference><Reference><Citation>Zizzo G, Cohen PL. Imperfect storm: is interleukin&#x2010;33 the Achilles heel of COVID&#x2010;19? Lancet Rheumatol. 2020;2(12):e779&#x2010;e790. 10.1016/S2665-9913(20)30340-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2665-9913(20)30340-4</ArticleId><ArticleId IdType="pmc">PMC7546716</ArticleId><ArticleId IdType="pubmed">33073244</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans RA, McAuley H, Harrison EM, et al. Physical, cognitive, and mental health impacts of COVID&#x2010;19 after hospitalisation (PHOSP&#x2010;COVID): a UK multicentre, prospective cohort study. &#xa0;Lancet Respir&#xa0;Med. 2021;9(11):1275&#x2010;1287. 10.1016/S2213-2600(21)00383-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00383-0</ArticleId><ArticleId IdType="pmc">PMC8497028</ArticleId><ArticleId IdType="pubmed">34627560</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y, Kilian C, Turner JE, et al. Clonal expansion and activation of tissue&#x2010;resident memory&#x2010;like TH17 cells expressing GM&#x2010;CSF in the lungs of patients with severe COVID&#x2010;19. Science Immunology. 2021;6(56):eabf6692. 10.1126/sciimmunol.abf6692</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abf6692</ArticleId><ArticleId IdType="pmc">PMC8128299</ArticleId><ArticleId IdType="pubmed">33622974</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J, Choi JA, Ju H, Kim JE, Paik SY, Rao PV. Role of MCP&#x2010;1 and IL&#x2010;8 in viral anterior uveitis, and contractility and fibrogenic activity of trabecular meshwork cells. Sci Rep. 2021;11(1):14950. 10.1038/s41598-021-94391-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-94391-2</ArticleId><ArticleId IdType="pmc">PMC8298573</ArticleId><ArticleId IdType="pubmed">34294770</ArticleId></ArticleIdList></Reference><Reference><Citation>Senoo S, Taniguchi A, Itano J, et al. Essential role of IL&#x2010;23 in the development of acute exacerbation of pulmonary fibrosis. Am&#xa0;J&#xa0;Physiol. 2021;321(5):L925&#x2010;L940. 10.1152/ajplung.00582.2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00582.2020</ArticleId><ArticleId IdType="pubmed">34524907</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao H, Li H, Wang JJ, et al. IL&#x2010;18 cleavage triggers cardiac inflammation and fibrosis upon &#x3b2;&#x2010;adrenergic insult. Eur Heart J. 2018;39(1):60&#x2010;69. 10.1093/eurheartj/ehx261</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehx261</ArticleId><ArticleId IdType="pubmed">28549109</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang LM, Zhang J, Zhang Y, et al. Interleukin&#x2010;18 promotes fibroblast senescence in pulmonary fibrosis through down&#x2010;regulating Klotho expression. Biomed Pharmacother. 2019;113:108756. 10.1016/j.biopha.2019.108756</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2019.108756</ArticleId><ArticleId IdType="pubmed">30870716</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinnon KH 3rd, Leist SR, Okuda K, et al. SARS&#x2010;CoV&#x2010;2 infection produces chronic pulmonary epithelial and immune cell dysfunction with fibrosis in mice. Sci Transl Med. 2022;14:eabo5070. 10.1126/scitranslmed.abo5070</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abo5070</ArticleId><ArticleId IdType="pmc">PMC9273046</ArticleId><ArticleId IdType="pubmed">35857635</ArticleId></ArticleIdList></Reference><Reference><Citation>McGroder CF, Zhang D, Choudhury MA, et al. Pulmonary fibrosis 4 months after COVID&#x2010;19 is associated with severity of illness and blood leucocyte telomere length. Thorax. 2021;76(12):1242&#x2010;1245. 10.1136/thoraxjnl-2021-217031</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2021-217031</ArticleId><ArticleId IdType="pmc">PMC8103561</ArticleId><ArticleId IdType="pubmed">33927016</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>